Prediction of response to neoadjuvant chemo-immunotherapy in patients with esophageal squamous cell carcinoma by a rapid breath test-Reference-Cited by-同舟云学术

Prediction of response to neoadjuvant chemo-immunotherapy in patients with esophageal squamous cell carcinoma by a rapid breath test

Published:2024-01-04 Issue:4 Volume:130 Page:694-700
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Huang Qi,Liu Zheng,Yu Yipei,Rong Zhiwei,Wang Peiyu,Wang Shaodong,Wu Hao,Yan Xiang,Cho William C.^ORCID,Mu Teng,Li Jilun,Zhao Jia,Qiu Mantang^ORCID,Hou Yan,Li Xiangnan^ORCID

Funder

National Natural Science Foundation of China

Beijing Nova Program

Peking University People’s Hospital Research and Development Founds is a research fund established within Peking University People’s Hospital.

Research Project of Shenzhen Second People’s Hospital is a research fund established within Shenzhen Second People’s Hospital.

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41416-023-02547-w.pdf

Reference40 articles.

1. Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 2018;154:360–73.

2. Sun JM, Shen L, Shah MA, Enzinger P, Adenis A, Doi T, et al. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study. Lancet. 2021;398:759–71.

3. Topalian SL, Taube JM, Pardoll DM. Science. 2020;367:eaax0182.

4. He S, Xu J, Liu X, Zhen Y. Advances and challenges in the treatment of esophageal cancer. Front Oncol 2020;10:763.

5. Sundar R, Smyth EC, Peng S, Yeong JPS, Tan P. Predictive biomarkers of immune checkpoint inhibition in gastroesophageal cancers. Front Oncol. 2020;10:763.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A machine learning radiomics based on enhanced computed tomography to predict neoadjuvant immunotherapy for resectable esophageal squamous cell carcinoma;Frontiers in Immunology;2024-06-14